학술논문
Predictive significance of inflammatory markers and mGPS in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide
Document Type
Article
Author
Source
In: Cancer Chemotherapy and Pharmacology . (Cancer Chemotherapy and Pharmacology, January 2024, 93(1):71-78)
Subject
Language
English
ISSN
14320843
03445704
03445704